NOP 2/Sun RNA methyltransferase 2 promotes tumor progression via its interacting partner RPL 6 in gallbladder carcinoma
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
NOP
2/Sun
RNA
methyltransferase 2 promotes tumor progression via its interacting partner
RPL
6 in gallbladder carcinoma
Authors
Keywords
-
Journal
CANCER SCIENCE
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2019-09-06
DOI
10.1111/cas.14190
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Ribosomal protein L6 (RPL6) is recruited to DNA damage sites in a poly (ADP-ribose) polymerase-dependent manner and regulates the DNA damage response
- (2019) Chuanzhen Yang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- High tRNA Transferase NSUN2 Gene Expression is Associated with Poor Prognosis in Head and Neck Squamous Carcinoma
- (2018) Lingeng Lu et al. CANCER INVESTIGATION
- GenomicERBB2/ERBB3mutations promote PD-L1-mediated immune escape in gallbladder cancer: a whole-exome sequencing analysis
- (2018) Maolan Li et al. GUT
- Changing cancer survival in China during 2003–15: a pooled analysis of 17 population-based cancer registries
- (2018) Hongmei Zeng et al. Lancet Global Health
- OUP accepted manuscript
- (2018) NUCLEIC ACIDS RESEARCH
- E2F1 and E2F7 differentially regulate KPNA2 to promote the development of gallbladder cancer
- (2018) Shanshan Xiang et al. ONCOGENE
- Gallbladder cancer epidemiology, pathogenesis and molecular genetics: Recent update
- (2017) Aarti Sharma et al. WORLD JOURNAL OF GASTROENTEROLOGY
- EIF3D promotes gallbladder cancer development by stabilizing GRK2 kinase and activating PI3K-AKT signaling pathway
- (2017) Fei Zhang et al. Cell Death & Disease
- mRNA methylation by NSUN2 in cell proliferation
- (2016) Wengong Wang Wiley Interdisciplinary Reviews-RNA
- NSun2 delays replicative senescence by repressing p27 (KIP1) translation and elevating CDK1 translation
- (2015) Hao Tang et al. Aging-US
- NSun2 Promotes Cell Growth via Elevating Cyclin-Dependent Kinase 1 Translation
- (2015) Junyue Xing et al. MOLECULAR AND CELLULAR BIOLOGY
- SPOCK1 as a potential cancer prognostic marker promotes the proliferation and metastasis of gallbladder cancer cells by activating the PI3K/AKT pathway
- (2015) Yi-Jun Shu et al. Molecular Cancer
- Whole-exome and targeted gene sequencing of gallbladder carcinoma identifies recurrent mutations in the ErbB pathway
- (2014) Maolan Li et al. NATURE GENETICS
- tRNA Modifying Enzymes, NSUN2 and METTL1, Determine Sensitivity to 5-Fluorouracil in HeLa Cells
- (2014) Mayumi Okamoto et al. PLoS Genetics
- Identification of direct targets and modified bases of RNA cytosine methyltransferases
- (2013) Vahid Khoddami et al. NATURE BIOTECHNOLOGY
- Regulation of the HDM2-p53 pathway by ribosomal protein L6 in response to ribosomal stress
- (2013) Dongmei Bai et al. NUCLEIC ACIDS RESEARCH
- NSun2-Mediated Cytosine-5 Methylation of Vault Noncoding RNA Determines Its Processing into Regulatory Small RNAs
- (2013) Shobbir Hussain et al. Cell Reports
- Frequent Increased Gene Copy Number and High Protein Expression of tRNA (Cytosine-5-)-Methyltransferase (NSUN2) in Human Cancers
- (2011) Mayumi Okamoto et al. DNA AND CELL BIOLOGY
- Downregulation of RPL6 by siRNA Inhibits Proliferation and Cell Cycle Progression of Human Gastric Cancer Cell Lines
- (2011) Qiong Wu et al. PLoS One
- Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer
- (2010) Juan Valle et al. NEW ENGLAND JOURNAL OF MEDICINE
- The nucleolar RNA methyltransferase Misu (NSun2) is required for mitotic spindle stability
- (2009) Shobbir Hussain et al. JOURNAL OF CELL BIOLOGY
- Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
- (2009) Da Wei Huang et al. Nature Protocols
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started